{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:47:35Z","timestamp":1789447655904,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0293"],"award-info":[{"award-number":["W81XWH-20-1-0293"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0392"],"award-info":[{"award-number":["W81XWH-19-1-0392"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R61NS117210"],"award-info":[{"award-number":["R61NS117210"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["1072634"],"award-info":[{"award-number":["1072634"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003975","name":"Myotonic Dystrophy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-56479-5","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T10:03:02Z","timestamp":1741168982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of human urinary extracellular vesicles reveals disordered renal metabolism in myotonic dystrophy type 1"],"prefix":"10.1038","volume":"16","author":[{"given":"Preeti","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Parker Conquest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Cornforth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rojashree","family":"Jayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4472-1945","authenticated-orcid":false,"given":"Ningyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4417-5908","authenticated-orcid":false,"given":"J.","family":"Alexander Sizemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6360-2520","authenticated-orcid":false,"given":"Brigham B.","family":"McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Kitchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Gonz\u00e1lez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Linville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soleil","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise L.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil T.","family":"Darras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seward B.","family":"Rutkove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0851-3516","authenticated-orcid":false,"given":"Susan T.","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0652-6703","authenticated-orcid":false,"given":"Paula R.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araya","family":"Puwanant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9486-6811","authenticated-orcid":false,"given":"Sudeshna","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thurman M.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"56479_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/WCO.0000000000000128","volume":"27","author":"C Turner","year":"2014","unstructured":"Turner, C. & Hilton-Jones, D. Myotonic dystrophy: diagnosis, management and new therapies. Curr. Opin. Neurol. 27, 599\u2013606 (2014).","journal-title":"Curr. Opin. Neurol."},{"key":"56479_CR2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/0026-0495(91)90017-Q","volume":"40","author":"AJ Krentz","year":"1991","unstructured":"Krentz, A. J., Williams, A. C. & Nattrass, M. Insulin resistance in multiple aspects of intermediary metabolism in myotonic dystrophy. Metabolism 40, 866\u2013872 (1991).","journal-title":"Metabolism"},{"key":"56479_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1212\/CPJ.0000000000000531","volume":"8","author":"T Ashizawa","year":"2018","unstructured":"Ashizawa, T. et al. Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol. Clin. Pr. 8, 507\u2013520 (2018).","journal-title":"Neurol. Clin. Pr."},{"key":"56479_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","volume":"68","author":"JD Brook","year":"1992","unstructured":"Brook, J. D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2019 end of a transcript encoding a protein kinase family member. Cell 68, 799\u2013808 (1992).","journal-title":"Cell"},{"key":"56479_CR5","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/hmg\/ddz055","volume":"28","author":"G Overend","year":"2019","unstructured":"Overend, G. et al. Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes. Hum. Mol. Genet. 28, 2245\u20132254 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"56479_CR6","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1093\/emboj\/19.17.4439","volume":"19","author":"JW Miller","year":"2000","unstructured":"Miller, J. W. et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19, 4439\u20134448 (2000).","journal-title":"EMBO J."},{"key":"56479_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molcel.2007.07.027","volume":"28","author":"NM Kuyumcu-Martinez","year":"2007","unstructured":"Kuyumcu-Martinez, N. M., Wang, G. S. & Cooper, T. A. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell 28, 68\u201378 (2007).","journal-title":"Mol. Cell"},{"key":"56479_CR8","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1101\/gr.184390.114","volume":"25","author":"ET Wang","year":"2015","unstructured":"Wang, E. T. et al. Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins. Genome Res. 25, 858\u2013871 (2015).","journal-title":"Genome Res."},{"key":"56479_CR9","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1062125","volume":"293","author":"CL Liquori","year":"2001","unstructured":"Liquori, C. L. et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293, 864\u2013867 (2001).","journal-title":"Science"},{"key":"56479_CR10","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1093\/hmg\/ddl132","volume":"15","author":"X Lin","year":"2006","unstructured":"Lin, X. et al. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet. 15, 2087\u20132097 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"56479_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/kisup.2012.64","volume":"3","author":"Chapter 1.","year":"2013","unstructured":"Chapter 1. Definition and classification of CKD. Kidney Int. Suppl. 3, 19\u201362 (2013).","journal-title":"Kidney Int. Suppl."},{"key":"56479_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jns.2016.07.036","volume":"368","author":"T Matsumura","year":"2016","unstructured":"Matsumura, T. et al. Renal dysfunction can be a common complication in patients with myotonic dystrophy 1. J. Neurol. Sci. 368, 266\u2013271 (2016).","journal-title":"J. Neurol. Sci."},{"key":"56479_CR13","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.nmd.2017.08.002","volume":"27","author":"A Aldenbratt","year":"2017","unstructured":"Aldenbratt, A., Lindberg, C. & Svensson, M. K. Reduced renal function in patients with myotonic dystrophy type 1 and the association to CTG expansion and other potential risk factors for chronic kidney disease. Neuromuscul. Disord. 27, 1038\u20131042 (2017).","journal-title":"Neuromuscul. Disord."},{"key":"56479_CR14","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","volume":"164","author":"M Tkach","year":"2016","unstructured":"Tkach, M. & Thery, C. Communication by extracellular vesicles: where we are and where we need to go. Cell 164, 1226\u20131232 (2016).","journal-title":"Cell"},{"key":"56479_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1681\/ASN.2015010074","volume":"27","author":"U Erdbrugger","year":"2016","unstructured":"Erdbrugger, U. & Le, T. H. Extracellular vesicles in renal diseases: more than novel biomarkers? J. Am. Soc. Nephrol. 27, 12\u201326 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"56479_CR16","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","volume":"186","author":"R Kalluri","year":"2023","unstructured":"Kalluri, R. & McAndrews, K. M. The role of extracellular vesicles in cancer. Cell 186, 1610\u20131626 (2023).","journal-title":"Cell"},{"key":"56479_CR17","doi-asserted-by":"publisher","first-page":"e13346","DOI":"10.1111\/apha.13346","volume":"228","author":"P Svenningsen","year":"2020","unstructured":"Svenningsen, P., Sabaratnam, R. & Jensen, B. L. Urinary extracellular vesicles: origin, role as intercellular messengers and biomarkers; efficient sorting and potential treatment options. Acta Physiol. 228, e13346 (2020).","journal-title":"Acta Physiol."},{"key":"56479_CR18","doi-asserted-by":"publisher","first-page":"13368","DOI":"10.1073\/pnas.0403453101","volume":"101","author":"T Pisitkun","year":"2004","unstructured":"Pisitkun, T., Shen, R. F. & Knepper, M. A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 101, 13368\u201313373 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"56479_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06206-0","volume":"9","author":"L Antoury","year":"2018","unstructured":"Antoury, L. et al. Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies. Nat. Commun. 9, 3906 (2018).","journal-title":"Nat. Commun."},{"key":"56479_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"56479_CR21","doi-asserted-by":"publisher","unstructured":"Raychaudhuri, S., Stuart, J. M. & Altman, R. B. Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac. Symp. Biocomput. 455\u2013466 https:\/\/doi.org\/10.1142\/9789814447331_0043 (2000).","DOI":"10.1142\/9789814447331_0043"},{"key":"56479_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nbt0308-303","volume":"26","author":"M Ringner","year":"2008","unstructured":"Ringner, M. What is principal component analysis? Nat. Biotechnol. 26, 303\u2013304 (2008).","journal-title":"Nat. Biotechnol."},{"key":"56479_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"56479_CR24","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"56479_CR25","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"56479_CR26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1212\/WNL.56.3.336","volume":"56","author":"J Mathieu","year":"2001","unstructured":"Mathieu, J. et al. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 56, 336\u2013340 (2001).","journal-title":"Neurology"},{"key":"56479_CR27","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1681\/ASN.2014111067","volume":"26","author":"JW Lee","year":"2015","unstructured":"Lee, J. W., Chou, C. L. & Knepper, M. A. Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes. J. Am. Soc. Nephrol. 26, 2669\u20132677 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"56479_CR28","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1681\/ASN.2020010071","volume":"31","author":"K Limbutara","year":"2020","unstructured":"Limbutara, K., Chou, C. L. & Knepper, M. A. Quantitative proteomics of all 14 renal tubule segments in rat. J. Am. Soc. Nephrol. 31, 1255\u20131266 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"56479_CR29","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s002040000173","volume":"74","author":"A Dorrenhaus","year":"2000","unstructured":"Dorrenhaus, A. et al. Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system. Arch. Toxicol. 74, 618\u2013626 (2000).","journal-title":"Arch. Toxicol."},{"key":"56479_CR30","doi-asserted-by":"publisher","first-page":"100303","DOI":"10.1016\/j.xpro.2021.100303","volume":"2","author":"P Chhoy","year":"2021","unstructured":"Chhoy, P., Brown, C. W., Amante, J. J. & Mercurio, A. M. Protocol for the separation of extracellular vesicles by ultracentrifugation from in vitro cell culture models. STAR Protoc. 2, 100303 (2021).","journal-title":"STAR Protoc."},{"key":"56479_CR31","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1093\/hmg\/ddh327","volume":"13","author":"H Jiang","year":"2004","unstructured":"Jiang, H. et al. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 13, 3079\u20133088 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"56479_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108634","volume":"34","author":"BA Otero","year":"2021","unstructured":"Otero, B. A. et al. Transcriptome alterations in myotonic dystrophy frontal cortex. Cell Rep. 34, 108634 (2021).","journal-title":"Cell Rep."},{"key":"56479_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v018.i02","volume":"18","author":"B-H Mevik","year":"2007","unstructured":"Mevik, B.-H. & Wehrens, R. The pls Package: principal component and partial least squares regression in R. J. Stat. Softw. 18, 1\u201324 (2007).","journal-title":"J. Stat. Softw."},{"key":"56479_CR34","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1006\/bbrc.2000.3694","volume":"277","author":"N Takahashi","year":"2000","unstructured":"Takahashi, N., Sasagawa, N., Suzuki, K. & Ishiura, S. The CUG-binding protein binds specifically to UG dinucleotide repeats in a yeast three-hybrid system. Biochem. Biophys. Res. Commun. 277, 518\u2013523 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"56479_CR35","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/hmg\/ddp570","volume":"19","author":"M Koshelev","year":"2010","unstructured":"Koshelev, M. et al. Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1. Hum. Mol. Genet. 19, 1066\u20131075 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"56479_CR36","doi-asserted-by":"crossref","unstructured":"Driesen, K. & Witters, P. Understanding inborn errors of metabolism through metabolomics. Metabolites 12, 398 (2022).","DOI":"10.3390\/metabo12050398"},{"key":"56479_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jimd.12446","volume":"45","author":"P Vieira","year":"2022","unstructured":"Vieira, P. et al. Cytosolic phosphoenolpyruvate carboxykinase deficiency: expanding the clinical phenotype and novel laboratory findings. J. Inherit. Metab. Dis. 45, 223\u2013234 (2022).","journal-title":"J. Inherit. Metab. Dis."},{"key":"56479_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymgme.2022.07.007","volume":"137","author":"M Goetz","year":"2022","unstructured":"Goetz, M. et al. Genotypic and phenotypic spectrum of cytosolic phosphoenolpyruvate carboxykinase deficiency. Mol. Genet. Metab. 137, 18\u201325 (2022).","journal-title":"Mol. Genet. Metab."},{"key":"56479_CR39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1006\/mgme.2000.3085","volume":"71","author":"K Tomoeda","year":"2000","unstructured":"Tomoeda, K. et al. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria. Mol. Genet. Metab. 71, 506\u2013510 (2000).","journal-title":"Mol. Genet. Metab."},{"key":"56479_CR40","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bbadis.2010.03.013","volume":"1802","author":"AB van Kuilenburg","year":"2010","unstructured":"van Kuilenburg, A. B. et al. Dihydropyrimidinase deficiency: phenotype, genotype and structural consequences in 17 patients. Biochim. Biophys. Acta 1802, 639\u2013648 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"56479_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1086\/500563","volume":"78","author":"JO Sass","year":"2006","unstructured":"Sass, J. O. et al. Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. Am. J. Hum. Genet. 78, 401\u2013409 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"56479_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0117-5","volume":"9","author":"SC Grunert","year":"2014","unstructured":"Grunert, S. C. Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency. Orphanet J. Rare Dis. 9, 117 (2014).","journal-title":"Orphanet J. Rare Dis."},{"key":"56479_CR43","first-page":"708","volume":"48","author":"A Kumps","year":"2002","unstructured":"Kumps, A., Duez, P. & Mardens, Y. Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin. Chem. 48, 708\u2013717 (2002).","journal-title":"Clin. Chem."},{"key":"56479_CR44","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.nmd.2015.01.008","volume":"25","author":"C Gagnon","year":"2015","unstructured":"Gagnon, C. et al. Report of the second outcome measures in myotonic dystrophy type 1 (OMMYD-2) international workshop San Sebastian, Spain, October 16, 2013. Neuromuscul. Disord. 25, 603\u2013616 (2015).","journal-title":"Neuromuscul. Disord."},{"key":"56479_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.105933","volume":"165","author":"SJ Halliday","year":"2020","unstructured":"Halliday, S. J. et al. Six-minute walk distance in healthy young adults. Respir. Med. 165, 105933 (2020).","journal-title":"Respir. Med."},{"key":"56479_CR46","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1164\/ajrccm.158.5.9710086","volume":"158","author":"PL Enright","year":"1998","unstructured":"Enright, P. L. & Sherrill, D. L. Reference equations for the six-minute walk in healthy adults. Am. J. Respir. Crit. Care Med. 158, 1384\u20131387 (1998).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"56479_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10157-012-0681-8","volume":"17","author":"K Hiraki","year":"2013","unstructured":"Hiraki, K. et al. Decreased physical function in pre-dialysis patients with chronic kidney disease. Clin. Exp. Nephrol. 17, 225\u2013231 (2013).","journal-title":"Clin. Exp. Nephrol."},{"key":"56479_CR48","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1212\/WNL.52.8.1658","volume":"52","author":"J Mathieu","year":"1999","unstructured":"Mathieu, J. et al. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 52, 1658\u20131662 (1999).","journal-title":"Neurology"},{"key":"56479_CR49","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jamda.2018.12.013","volume":"20","author":"T Kera","year":"2019","unstructured":"Kera, T. et al. Definition of respiratory sarcopenia with peak expiratory flow rate. J. Am. Med. Dir. Assoc. 20, 1021\u20131025 (2019).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"56479_CR50","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1212\/WNL.0b013e318260cbe6","volume":"79","author":"C Heatwole","year":"2012","unstructured":"Heatwole, C. et al. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology 79, 348\u2013357 (2012).","journal-title":"Neurology"},{"key":"56479_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/10253890.2018.1494150","volume":"22","author":"J Hadrevi","year":"2019","unstructured":"Hadrevi, J. et al. Plasma metabolomic patterns in patients with exhaustion disorder. Stress 22, 17\u201326 (2019).","journal-title":"Stress"},{"key":"56479_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/mus.23478","volume":"47","author":"MC Hermans","year":"2013","unstructured":"Hermans, M. C. et al. Fatigue and daytime sleepiness scale in myotonic dystrophy type 1. Muscle Nerve 47, 89\u201395 (2013).","journal-title":"Muscle Nerve"},{"key":"56479_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neulet.2011.08.006","volume":"503","author":"Y Masaoka","year":"2011","unstructured":"Masaoka, Y. et al. Impairment of odor recognition and odor-induced emotions in type 1 myotonic dystrophy. Neurosci. Lett. 503, 163\u2013166 (2011).","journal-title":"Neurosci. Lett."},{"key":"56479_CR54","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0031-9384(84)90269-5","volume":"32","author":"RL Doty","year":"1984","unstructured":"Doty, R. L., Shaman, P. & Dann, M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol. Behav. 32, 489\u2013502 (1984).","journal-title":"Physiol. Behav."},{"key":"56479_CR55","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1586\/erm.09.41","volume":"9","author":"J Ostrowski","year":"2009","unstructured":"Ostrowski, J. & Wyrwicz, L. S. Integrating genomics, proteomics and bioinformatics in translational studies of molecular medicine. Expert Rev. Mol. Diagn. 9, 623\u2013630 (2009).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"56479_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-022-00247-4","volume":"8","author":"R Yue","year":"2022","unstructured":"Yue, R. & Dutta, A. Computational systems biology in disease modeling and control, review and perspectives. NPJ Syst. Biol. Appl. 8, 37 (2022).","journal-title":"NPJ Syst. Biol. Appl."},{"key":"56479_CR57","first-page":"3952","volume":"117","author":"TM Wheeler","year":"2007","unstructured":"Wheeler, T. M. et al. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J. Clin. Investig. 117, 3952\u20133957 (2007).","journal-title":"J. Clin. Investig."},{"key":"56479_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37619-1","volume":"14","author":"N Hu","year":"2023","unstructured":"Hu, N., Kim, E., Antoury, L. & Wheeler, T. M. Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy. Nat. Commun. 14, 1956 (2023).","journal-title":"Nat. Commun."},{"key":"56479_CR59","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41581-021-00498-0","volume":"18","author":"XH Wang","year":"2022","unstructured":"Wang, X. H., Mitch, W. E. & Price, S. R. Pathophysiological mechanisms leading to muscle loss in chronic kidney disease. Nat. Rev. Nephrol. 18, 138\u2013152 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"56479_CR60","doi-asserted-by":"crossref","unstructured":"Heitman, K., Alexander, M. S. & Faul, C. Skeletal muscle injury in chronic kidney disease-from histologic changes to molecular mechanisms and to novel therapies. Int. J. Mol. Sci. 25, 5117 (2024).","DOI":"10.3390\/ijms25105117"},{"key":"56479_CR61","doi-asserted-by":"publisher","first-page":"F532","DOI":"10.1152\/ajprenal.00038.2023","volume":"324","author":"T Verissimo","year":"2023","unstructured":"Verissimo, T. et al. PCK1 is a key regulator of metabolic and mitochondrial functions in renal tubular cells. Am. J. Physiol. Ren. Physiol. 324, F532\u2013F543 (2023).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"56479_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1210\/en.2018-00630","volume":"160","author":"SA Beddow","year":"2019","unstructured":"Beddow, S. A. et al. PEPCK1 antisense oligonucleotide prevents adiposity and impairs hepatic glycogen synthesis in high-fat male fed rats. Endocrinology 160, 205\u2013219 (2019).","journal-title":"Endocrinology"},{"key":"56479_CR63","doi-asserted-by":"publisher","first-page":"32844","DOI":"10.1074\/jbc.M706127200","volume":"282","author":"P Hakimi","year":"2007","unstructured":"Hakimi, P. et al. Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse. J. Biol. Chem. 282, 32844\u201332855 (2007).","journal-title":"J. Biol. Chem."},{"key":"56479_CR64","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.biochi.2008.03.009","volume":"90","author":"RW Hanson","year":"2008","unstructured":"Hanson, R. W. & Hakimi, P. Born to run; the story of the PEPCK-Cmus mouse. Biochimie 90, 838\u2013842 (2008).","journal-title":"Biochimie"},{"key":"56479_CR65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1056\/NEJMp1604033","volume":"375","author":"GH Lyman","year":"2016","unstructured":"Lyman, G. H. & Moses, H. L. Biomarker tests for molecularly targeted therapies-the key to unlocking precision medicine. New Engl. J. Med. 375, 4\u20136 (2016).","journal-title":"New Engl. J. Med."},{"key":"56479_CR66","unstructured":"BEST (Biomarkers, EndpointS, and other Tools) Resource (FDA-NIH Biomarker Working Group, Silver Spring (MD), 2016). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK326791\/"},{"key":"56479_CR67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1743-7075-2-33","volume":"2","author":"P Hakimi","year":"2005","unstructured":"Hakimi, P. et al. Phosphoenolpyruvate carboxykinase and the critical role of cataplerosis in the control of hepatic metabolism. Nutr. Metab. 2, 33 (2005).","journal-title":"Nutr. Metab."},{"key":"56479_CR68","doi-asserted-by":"publisher","first-page":"145407","DOI":"10.1016\/j.gene.2021.145407","volume":"776","author":"BJ Henriques","year":"2021","unstructured":"Henriques, B. J., Katrine Jentoft Olsen, R., Gomes, C. M. & Bross, P. Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease. Gene 776, 145407 (2021).","journal-title":"Gene"},{"key":"56479_CR69","doi-asserted-by":"publisher","first-page":"19786","DOI":"10.1074\/jbc.R112.357194","volume":"287","author":"SC Kalhan","year":"2012","unstructured":"Kalhan, S. C. & Hanson, R. W. Resurgence of serine: an often neglected but indispensable amino acid. J. Biol. Chem. 287, 19786\u201319791 (2012).","journal-title":"J. Biol. Chem."},{"key":"56479_CR70","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1042\/cs0710429","volume":"71","author":"RT Moxley","year":"1986","unstructured":"Moxley, R. T. et al. Insulin resistance and regulation of serum amino acid levels in myotonic dystrophy. Clin. Sci. 71, 429\u2013436 (1986).","journal-title":"Clin. Sci."},{"key":"56479_CR71","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41385-022-00565-0","volume":"15","author":"NV Jafari","year":"2022","unstructured":"Jafari, N. V. & Rohn, J. L. The urothelium: a multi-faceted barrier against a harsh environment. Mucosal Immunol. 15, 1127\u20131142 (2022).","journal-title":"Mucosal Immunol."},{"key":"56479_CR72","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R. et al. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"56479_CR73","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","volume":"23","author":"T Koressaar","year":"2007","unstructured":"Koressaar, T. & Remm, M. Enhancements and modifications of primer design program Primer3. Bioinformatics 23, 1289\u20131291 (2007).","journal-title":"Bioinformatics"},{"key":"56479_CR74","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser, A. et al. Primer3-new capabilities and interfaces. Nucleic Acids Res. 40, e115 (2012).","journal-title":"Nucleic Acids Res."},{"key":"56479_CR75","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/hmg\/10.19.2165","volume":"10","author":"A Mankodi","year":"2001","unstructured":"Mankodi, A. et al. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 10, 2165\u20132170 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"56479_CR76","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.omtn.2020.11.014","volume":"23","author":"N Hu","year":"2021","unstructured":"Hu, N. et al. Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy. Mol. Ther. Nucleic Acids 23, 393\u2013405 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"56479_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07517-y","volume":"9","author":"N Hu","year":"2018","unstructured":"Hu, N. et al. Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1. Nat. Commun. 9, 5227 (2018).","journal-title":"Nat. Commun."},{"key":"56479_CR78","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00415-017-8399-x","volume":"264","author":"G DiPaolo","year":"2017","unstructured":"DiPaolo, G. et al. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA). J. Neurol. 264, 701\u2013708 (2017).","journal-title":"J. Neurol."},{"key":"56479_CR79","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris, P. A. et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inf. 42, 377\u2013381 (2009).","journal-title":"J. Biomed. Inf."},{"key":"56479_CR80","unstructured":"Kumari, P. https:\/\/BioRender.com\/s97f089 (2025)."},{"key":"56479_CR81","unstructured":"Kumari, P. https:\/\/BioRender.com\/t33c158 (2025)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56479-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T10:03:10Z","timestamp":1741168990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56479-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56479"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56479-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.G.H. and T.M.W. have been awarded a patent (U.S. patent number 11,866,782 B2; International patent application number PCT\/2017\/043348) for the use of extracellular RNA to identify markers of muscular dystrophies. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2158"}}